Skip to main content

Home/ Cancer/ Contents contributed and discussions participated by Matti Narkia

Contents contributed and discussions participated by Matti Narkia

Matti Narkia

An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of o... - 0 views

  •  
    Grant WB, Garland CF, Gorham ED. An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day. Recent Results Cancer Res. 2007;174:225-34. PMID: 17302200 [PubMed - in process]
Matti Narkia

Prostate cancer prevention by silibinin. - Entrez PubMed - 0 views

  •  
    Singh RP, Agarwal R. Prostate cancer prevention by silibinin. Curr Cancer Drug Targets. 2004 Feb;4(1):1-11. Review. PMID: 14965263 [PubMed - indexed for MEDLINE]
Matti Narkia

Curative Brachytherapy for Recurrent/Residual Tongue Cancer - Entrez PubMed - 0 views

  •  
    Ayukawa F, Shibuya H, Yoshimura RI, Watanabe H, Miura M. Curative Brachytherapy for Recurrent/Residual Tongue Cancer. Strahlenther Onkol. 2007 Mar;183(3):133-137. PMID: 17340071 [PubMed - as supplied by publisher]
Matti Narkia

Prostate cancer chemoprevention by silibinin: bench to bedside. - Entrez PubMed - 0 views

  •  
    Singh RP, Agarwal R. Prostate cancer chemoprevention by silibinin: bench to bedside. Mol Carcinog. 2006 Jun;45(6):436-42. Review. PMID: 16637061 [PubMed - indexed for MEDLINE]
Matti Narkia

Zyflamend, a unique herbal preparation with nonselective COX inhibitory activity, induc... - 0 views

  •  
    Bemis DL, Capodice JL, Anastasiadis AG, Katz AE, Buttyan R. Zyflamend, a unique herbal preparation with nonselective COX inhibitory activity, induces apoptosis of prostate cancer cells that lack COX-2 expression. Nutr Cancer. 2005;52(2):202-12. PMID:
Matti Narkia

Zyflamend((R))-Mediated Inhibition of Human Prostate Cancer PC3 Cell Proliferation: Eff... - 0 views

  •  
    Yang P, Cartwright C, Chan D, Vijjeswarapu M, Ding J, Newman RA. Zyflamend((R))-Mediated Inhibition of Human Prostate Cancer PC3 Cell Proliferation: Effects on 12-LOX and Rb Protein Phosphorylation. Cancer Biol Ther. 2007 Feb 25;6(2) [Epub ahead of pr
Matti Narkia

Head and Neck Cancer: An Expert Interview With Dr. Roger B. Cohen - 0 views

  •  
    Innovations in the Treatment of Patients With Head and Neck Cancer: An Expert Interview With Dr. Roger B. Cohen
Matti Narkia

Nutrition and Prostate Cancer Guide - Prostate Cancer Foundation - 0 views

  •  
    The Nutrition and Prostate Cancer guide summarizes the "best of the best" data and information available in the research arena today, and is designed to help everyone affected by or at risk for prostate cancer understand how key nutritional strategies can
Matti Narkia

PLoS Medicine - A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor... - 0 views

  •  
    Li H, Stampfer MJ, Hollis JBW, Mucci LA, Gaziano JM, et al. (2007) A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer. PLoS Med 4(3): e103 doi:10.1371/journal.pmed.0040103
Matti Narkia

Eicosanoid metabolism in squamous cell carcinoma cell lines derived from primary and me... - 0 views

  •  
    Schroeder CP, Yang P, Newman RA, Lotan R. Eicosanoid metabolism in squamous cell carcinoma cell lines derived from primary and metastatic head and neck cancer and its modulation by celecoxib. Cancer Biol Ther. 2004 Sep;3(9):847-52. Epub 2004 Sep 18. P
Matti Narkia

Chemokines and squamous cancer of the head and neck: targets for therapeutic interventi... - 0 views

  •  
    Yeudall WA, Miyazaki H. Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention? Expert Rev Anticancer Ther. 2007 Mar;7(3):351-60. PMID: 17338654 [PubMed - in process]
Matti Narkia

Tetrathiomolybdate copper reduction anti-angiogenesis cancer treatment - anticopper, TM. - 0 views

  •  
    WARNING: This page was NOT created or approved by any doctor or medical researcher. The purpose of this page is to provide hard-to-find information on copper reduction cancer treatment, a new unapproved and experimental course of cancer treatment whose ef
Matti Narkia

Tetrathiomolybdate Copper Reduction Therapy as an Antiangiogenic Treatment for Lymphoma... - 0 views

  •  
    The article is written by lay individuals for information purposes only and is not to be used to diagnose or treat any disease. The document outlines therapeutic strategies which have not been clinically proven and may not be effective for lymphoma and ot
Matti Narkia

Tetrathiomolybdate: Cancer Protocol. The Treatment and Management of Cancer Today. A re... - 0 views

  •  
    If angiogenesis controls cancer growth, what controls angiogenesis? Researchers at the University of Michigan and the University of South Florida believe that the copper status is critical to the function growth factors.
« First ‹ Previous 421 - 440 of 512 Next › Last »
Showing 20 items per page